Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
  • Ask Questions
April 8, 2021 CD as API / CD derivatives / Drug delivery / Pharma applications

Cyclodextrins in Antiviral Therapeutics and Vaccines

The review of Braga et al. describes the various roles of cyclodextrins (CDs) in vaccines againstviruses and in antiviral therapeutics

Continue reading

April 7, 2021 CD derivatives / Drug delivery

FDA granted accelerated approval to umbralisib / HPBCD tablet

The Food and Drug Administration granted accelerated approval to umbralisib (Ukoniq, TG Therapeutics), a kinase inhibitor including PI3K-delta and casein

Continue reading

April 6, 2021 CD derivatives / Food

Encapsulation of menthol into cyclodextrin metal-organic frameworks

Cyclodextrin (CD)-metal-organic frameworks (MOFs) are developed as a new type of food-acceptable multi-porous material, which shows a great potential for

Continue reading

August 16, 2018 CD as API / Pharma applications

YouTube video: Progress on Niemann-Pick disease type C1 at the NIH Clinical Center

August 13, 2018 Events

National Cyclodextrin Symposium (35CDS) in Japan

35th National Cyclodextrin Symposium (35CDS) organized by the Society of Cyclodextrins, Japan will be held in Kofu on Sept. 6-7,

Continue reading

August 9, 2018 CD as API / Pharma applications

HPαCD More Effective than HPβCD Against Breast Cancer

Wittkowski et al. recently published their results on re-evaluation of three genome-wide association studies using computational biostatistics approach. The genetic

Continue reading

August 6, 2018 Drug delivery / E-ducation / Non-pharma applications / Pharma applications

Cyclodextrin. A Versatile Ingredient

IntechOpen leading publisher of open access books published a new book on cyclodextrins edited by P. Arora & N. Dhingra.

Continue reading

August 1, 2018 Drug delivery / E-ducation / Environmental / Non-pharma applications / Pharma applications

New books on cyclodextrins

Three new books on various aspects of cyclodextrin research and applications have been recently published. 1. Cyclodextrin Fundamentals, Reactivity and

Continue reading

August 1, 2018 CD as API / Pharma applications

First cannabidiol product approved by FDA as medication

Cannabis has been used for medicinal purposes for thousands of years. Its active compounds produce pharmacological effects throughout the body,

Continue reading

August 1, 2018 Events

József Szejtli Award in 2018

Nicolas Blanchemain, assistant professor at the University of Lille, received the 2018. Jozsef Szejtli Award, which was handed over by

Continue reading

July 31, 2018 Events

EuroCD2019

The 6th European Cyclodextrin Conference will be held in Santiago de Compostela on October 2–4, 2019. Seven plenary lectures will

Continue reading

July 31, 2018 CD as API / Pharma applications

HPBCD can cross the Brain-Blood Barrier

Matencio et al. reported in their recent paper that 92.8% of HPBCD administered intrathecally to a child suffering from Niemann

Continue reading

July 30, 2018 CD derivatives

Phosphates of cyclodextrin polymers

The synthesis of β-CD polymer phosphate sodium salts was worked out to be used for coating of metal-organic framework (MOF)

Continue reading

Posts navigation

«Previous Posts 1 … 57 58 59 60 Next Posts»

Recent Posts

  • Registration opened for virtual abridged meeting prior to International Cyclodextrin Symposium
  • Visible Light-Activatable Cyclodextrin-Conjugates for the Efficient Delivery of Nitric Oxide with Fluorescent Reporter and their Inclusion Complexes with Betaxolol
  • Evading Thermodynamic Constraints of Cyclodextrin-Drug Formulations
  • Cyclodextrins in Antiviral Therapeutics and Vaccines
  • FDA granted accelerated approval to umbralisib / HPBCD tablet

Tags

antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems Drugs FDA Food Gilead History HPBCD nanomedicine Nanoparticles nanotechnology Niemann Pick Disease Polymer remdesivir SBECD Special issue Synthesis Trappsol

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (9)
  • Analysis (14)
  • CD as API (106)
  • CD derivatives (140)
  • Cosmetics and toilettry (10)
  • Drug delivery (210)
  • E-ducation (41)
  • Environmental (44)
  • Events (102)
  • Food (60)
  • Gene delivery (6)
  • In Hungarian (4)
  • Non-pharma applications (103)
  • Other industrial use (36)
  • Pharma applications (373)
  • Supramolecular systems (7)
  • Uncategorized (23)

Top Posts

  • Registration opened for virtual abridged meeting prior to International Cyclodextrin Symposium
  • Visible Light-Activatable Cyclodextrin-Conjugates for the Efficient Delivery of Nitric Oxide with Fluorescent Reporter and their Inclusion Complexes with Betaxolol
  • Cyclodextrins in Antiviral Therapeutics and Vaccines
  • Evading Thermodynamic Constraints of Cyclodextrin-Drug Formulations
  • FDA granted accelerated approval to umbralisib / HPBCD tablet
  • The monograph of SBECD is official in the European Pharmacopeia
  • Nasal delivery with beta-cyclodextrin is approved; a short story of Baqsimi
  • How air fresheners work?
  • Host-guest chemistry for the treatment of leishmania
  • HPBCD is a unique component in Janssen's COVID-19 vaccine candidate

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 295 other subscribers